江苏诺和必拓

Novabio is a specialized biotechnology company based in China Medical City, Taizhou, focusing on high-end peptide synthesis and protein engineering services. The company provides a comprehensive range of CRO and CDMO solutions, including high-throughput peptide libraries, custom peptide synthesis, and recombinant protein expression. Novabio leverages advanced technology platforms to support drug discovery and development for pharmaceutical and research institutions globally. Their expertise extends to antibody development and the production of complex modified peptides, such as isotope-labeled and cyclic peptides. By integrating chemical synthesis with biological expression, Novabio facilitates the rapid advancement of therapeutic candidates from research to development.